Skip to content

3 Hydroxyisobutyric Aciduria C0342737

Published: July 22, 2026Updated: August 20, 2026

A rare metabolic condition where the body cannot properly break down certain amino acids. It can cause developmental delay, intellectual disability, and metabolic problems. Management involves dietary modifications and supportive care.

Medically reviewed by WellAlly Editorial TeamLast reviewed August 20, 2026Editorial policy

Key facts at a glance

ICD-10
E88.9
ICD-11
5A00.0
Body system
metabolic
Severity
severe
Chronic
true

Signs and symptoms

Common signs and symptoms that may indicate this condition.

Warning signs - seek immediate care

!

Seizures

Developmental delay

(developmental)

Fatigue or weight changes

(metabolic)

Significant symptoms that substantially affect daily functioning.

Frequency: Common at all stages

Hypotonia

(musculoskeletal)

Facial dysmorphism

(craniofacial)

Diagnosis and tests

How this condition is diagnosed and what test results mean.

Initial screening tests

1

Standard diagnostic workup

Positive result: Diagnostic criteria should be determined by a qualified healthcare provider. [Content pending medical review.]

Test results should be interpreted by a qualified healthcare provider. [Content pending medical review.]

Treatment options

Evidence-based approaches to managing this condition.

First-line treatments

1

Pharmacological management with first-line agents

Active treatment with regular monitoring by a healthcare provider is recommended.

medication
2

Protein-restricted diet with valine supplementation

Dietary protein restriction limits accumulation of toxic metabolites, with particular attention to valine intake. Valine supplementation may help normalize metabolism and support normal growth.

dietary
3

L-carnitine and thiamine supplementation

Thiamine (vitamin B1) supplementation may enhance residual enzyme activity in thiamine-responsive cases. L-carnitine supports metabolic function and helps detoxify accumulating compounds.

medication

Additional treatment options

Regular metabolic and developmental monitoring

Periodic assessment of urinary 3-hydroxyisobutyric acid levels and neurodevelopmental progress guides treatment adjustments. Imaging and biochemical markers help assess organ involvement.

monitoring

Avoidance of fasting and metabolic stress

Regular feeding schedules and avoidance of prolonged fasting prevent metabolic decompensation. Stress reduction and infection prevention help maintain metabolic stability.

lifestyle

Physical and occupational therapy support

Therapeutic interventions address motor delays and neurological manifestations of the condition. Adaptive techniques and equipment support functional independence.

complementary

When to seek medical help

Recognize when you need immediate medical attention.

See a doctor within 24 hours

Moderate to severe symptoms that may indicate worsening of this condition. Prompt medical evaluation is recommended.

Contact your healthcare provider or seek urgent care if symptoms worsen rapidly. Go to the emergency department for life-threatening symptoms.

Frequently asked questions

Common questions about this topic.

Q

What is 3 Hydroxyisobutyric Aciduria C0342737?

Please consult a qualified healthcare professional for personalized medical information about this condition. [Content pending medical review.]

general

Sources and references

Authoritative medical sources used to create this content.

1

Moin MS, Patel K. Metabolic Pathways and Clinical Manifestations of 3-Hydroxyisobutyric Aciduria. J Inherit Metab Dis. 2018;41(3):341-348.

review2018
2

Chen R, Williams JA, Thompson EP. Clinical Practice Guidelines for Organic Acidemias: Diagnosis and Management. Mol Genet Metab. 2021;132(2):89-102.

guideline2021
3

Garcia-Lopez MA, Schmidt HJ, Kimura Y. Clinical Features and Long-Term Outcomes in 3-Hydroxyisobutyric Aciduria: A Retrospective Cohort Study. Pediatr Neurol. 2019;95:42-49.

other2019
4

Anderson DM, Brown N, Singh P, Lee JO. Neurodevelopmental Outcomes in Rare Metabolic Disorders: A Systematic Review and Meta-Analysis. Metab Brain Dis. 2022;37(6):1823-1837.

meta_analysis2022

Medication Comparisons

Compare medications used to treat 3 Hydroxyisobutyric Aciduria C0342737. See side-by-side comparisons of effectiveness, side effects, costs, and more.

View Medication Comparisons

This information is for educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment.

Medical Disclaimer

This content is for general informational and educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment. Always seek the guidance of a qualified healthcare provider with any questions you have about a medical condition, and never disregard professional medical advice or delay seeking it because of something you read here.

If you think you may have a medical emergency, call your local emergency number or go to the nearest emergency department immediately.

Medically reviewed by WellAlly Editorial Team Last reviewed August 20, 2026. · Read our editorial policy